Discover 1,688 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,688
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
for
Heart Failure, Medication Optimization
Location: Denver CO
Sponsor: Denver Health and Hospital Authority
Sex: All
Age: 18+
Code: NCT07435662
Recruiting
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
for
Advanced Pheochromocytoma and Paraganglioma, PCPG
Location: Philadelphia PA, Ann Arbor MI, St Louis MO,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07282587
Phase 2, Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, Boston MA, Farmington CT, New Haven CT,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, White Plains NY, Schenectady NY, Montreal,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase 3, Recruiting
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, Dallas TX, San Antonio TX,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07372625
Phase 1, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase 2, Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
for
Liver Cirrhosis
Location: New York NY, Morehead City NC, Miami FL, Miami Lakes FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18 - 70+
Code: NCT07325526
Phase 2, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Bryn Mawr PA, Syracuse NY, North Charleston SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
for
Diabetes Mellitus Type 2, Childhood-Onset
Location: Boston MA, Garden City NY, The Bronx NY, New York NY,
Sponsor: George Washington University
Sex: All
Age: 8 - 15
Code: NCT06525259
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Boston MA, Quebec, Sherbrooke, New York NY, Montreal,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for
Lupus Erythematosus, Systemic
Location: Newark NJ, Voorhees Township NJ, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07438496
Phase 3, Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase 3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Moncton, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
Study of Placental Function in Healthy and Pathological Pregnancies
for
Pregnancy
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: Female
Age: 18 - 45
Code: NCT02321007
Recruiting
Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome
for
Pitt Hopkins Syndrome
Location: Chicago IL, Aurora CO, Oakland CA
Sponsor: Mahzi Therapeutics
Sex: All
Age: 2 - 25
Code: NCT07135050
Phase 1, Phase 2, Recruiting
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
for
Refractory Lupus Nephritis, Myasthaenia Gravis,
Location: Denver CO
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18+
Code: NCT07403188
Recruiting
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
for
Neoplasms, Colorectal, Neoplasms
Location: Toronto, Montreal, Hamilton, Canton OH, Detroit MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07213609
Phase 1, Phase 2, Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight